Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer: A Systematic Review

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.03.734
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide

Clinical Medicine Insights: Oncology
Oncology
2013English

Pcn388 - Patient Reported Outcomes in the Castration Resistant Prostate Cancer Registry (Pro-Capri) in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness Analyses and Cost Analyses in Castration-Resistant Prostate Cancer: A Systematic Review

PLoS ONE
Multidisciplinary
2018English

Economic Evaluations of Cabazitaxel for Treatment of Post-Docetaxel Metastatic Castration-Resistant Prostate Cancer: Evidence From a Systematic Review

Journal of Pharmaceutical Research International
2019English

Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prostate-Specific Membrane Antigen–Directed Therapy for Metastatic Castration-Resistant Prostate Cancer

Cancer Journal
Cancer ResearchOncology
2016English

Metastatic Castration-Resistant Prostate Cancer: The Emerging Continuum of Care

Journal of the Canadian Urological Association
OncologyUrology
2013English

Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer

Clinical Medicine Insights: Oncology
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy